Table 1 Demographic and clinical characteristics of participants.
Phakic eye | Pseudophakic eye | P value* | |
---|---|---|---|
Age (years) | 73.91 ± 10.61 | 75.18 ± 8.92 | 0.669 |
Follow-up period (years) | 5.25 ± 3.91 | 5.85 ± 4.19 | 0.615 |
Baseline medication | 0.18 ± 0.50 | 0.68 ± 0.78 | 0.016 |
Baseline IOP (mmHg) | 17.6 ± 3.7 | 15.9 ± 5.3 | 0.217† |
BCVA | 0.67 ± 0.15 | 0.70 ± 0.16 | 0.923 |
Spherical equivalent (D) | −0.12 ± 2.06 | –0.39 ± 1.24 | 0.597 |
Axial length (mm) | 23.59 ± 0.85 | 23.61 ± 1.19 | 0.955† |
ACD (mm) | 3.04 ± 0.35 | 3.95 ± 0.60 | < 0.001† |
MD (dB) | −4.59 ± 2.88 | -6.18 ± 4.34 | 0.337 |
PSD (dB) | 3.42 ± 2.87 | 5.32 ± 3.75 | 0.071 |
RNFL thickness (μm) | 78.61 ± 12.40 | 74.14 ± 12.53 | 0.350† |